Lightbody Lecture 20 Flashcards
degrad of purines
DNA and RNA digested to free bases by panc enz’s and abs in intestine; most ingested NAs are degraded to uric acid, excreted; inside cells, DNA and RNA deg’d to free bases, but reutilized; free bases used via salvage or converted to uric acid and excreted in urine; not used for E
xanthine oxidase
degrad of guanine nts; cont 2FAD, 2 molybdenum and 8 Fe; xanthine + H2O + O2 –> uric acid + H2O2; not mixed fxn oxygenase; O2 comes from H2O
degrad of adenine nts
adenosine deaminase converts adenosine and deoxyadenosine to inosine –> hypoxanthine thru salvage path (HGPRT) to AMP or to uric acid thru xanthine oxidase
gout
purine metab disease; affects joint of big toe but also feet, ankles, knees, hands, wrists; joint is hot, swollen, red, tender (inflam); 5-10d, then subside; chronic –>hard lumps of urate around joint, dec kidney fxn, kidney stones
gout physio causes
urate crystals accum around joint causing inflam, resulting when [uric acid] in blood > certain []; high [] from excess synth or dec excretion by kidneys (high serum urate)
gout causes
purine-rich diet (red meat, organ meats, yeasts); inc purine degrad; inc PRPP synthetase activity (inc purine synth and degrad, so inc urate prod); decreased/partial HGPRT activity, so inc HX and G, excess caffeine and alcohol; lead - urate excretion
gout treatment
increase fluids, diet (dec foods w/high [purine]), medication anti-inflam, allopurinol)
allopurinol
inhib xanthine oxidase, so can’t make uric acid from xanthine; allevs excess uric acid prod in Lesch-Nyhan pts, but doesn’t remedy neuro problems
SCIDS
inherited disorders of imm sys–>malfxn of both B and T cells; most common is adenosine deaminase (ADA) def; kids w/ADA def have non-fxning imm sys
adenosine deaminase rxn
adenosine–>inosine–>uric acid
adenosine deaminase deficiency
inhib ribonucleotide reductase; no DNA synth, no uric acid (can’t form deoxyadenosine, etc.; deoxyad gets rephos to dAMP, then to dADP and then dATP which inhibits rib reductase
treatment of ADA deficiency
bone marrow; enz replacement therapy, gene therapy
de novo synth of pyrimidines
synth before attach to ribose 5P, unlike purine synth; sources of atoms are Gln, CO2, Asp; 1st 3 enz activities are CAD, last two are UMP synthase
step 1: synth of carbamoyl P
Gln and HCO3- condense in presence of ATP; carbamoyl P synthetase exists in CPS-1 (mito enz, dedicated to urea cycle and Arg biosynth) and CPSII, a cytosolic enz in synth of pyrimidines
CPS II
major site of regul in animals; UDP and UTP inhibit enz, ATP and PRPP activate it; uses Gln (CPS I uses ammonia (urea cycle))